文献速递甲状腺疾病

肿瘤分级与分子特征同散发性甲状腺髓样癌生存的关联

Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma.
PubMed 文献 · Thyroid · 2023-12-27

该回顾性队列研究纳入2000年1月至2022年1月在帕多瓦内分泌外科接受初次手术的141例连续散发性甲状腺髓样癌患者,中位随访80.0个月。国际甲状腺髓样癌分级系统(IMTCGS)分级与疾病特异性生存独立相关(风险比8.8,置信区间2.7-28.3,p=0.005),且分级与RET和RAS突变模式相关。

要点

  • 141例散发性甲状腺髓样癌中,低级别107/141(76.9%),高级别32/141(23.1%)。
  • 多变量分析仅IMTCGS分级与疾病特异性生存独立相关(风险比8.8,置信区间2.7-28.3,p=0.005)。
  • 高级别较低级别RET突变更常见(68.8% vs 29.4%),RAS突变仅见于低级别(11.8%)。

核心结论

  • IMTCGS分级与其他临床、病理和分子因素无关地同疾病特异性生存相关。
  • 甲状腺髓样癌分级与RET和RAS突变模式相关,部分解释了高级别甲状腺髓样癌侵袭行为的分子基础。

研究设计与样本

  • 回顾性队列研究,纳入2000年1月至2022年1月在帕多瓦内分泌外科接受初次手术的141例连续散发性甲状腺髓样癌患者。
  • 收集体检、病理和随访数据,进行肿瘤分级,并分析RET和RAS基因体细胞突变。
  • 采用Kaplan-Meier法和log-rank检验进行生存分析,采用Cox比例风险回归模型进行多变量生存分析,协变量包括体细胞RET突变、诊断时MTC分期、性别、诊断时年龄和IMTCGS分级。

主要发现

  • 中位随访80.0个月(四分位距41.5-122.5个月),17例(12.1%)死于疾病相关原因。
  • 低级别肿瘤107/141(76.9%),高级别肿瘤32/141(23.1%)。
  • 携带RET突变的患者侵袭性特征更多,疾病特异性生存更短(p=0.001),且更常被归为高级别而非低级别MTC(p<0.001)。
  • 多变量生存分析中,仅IMTCGS分级与疾病特异性生存独立相关(风险比8.8,置信区间2.7-28.3,p=0.005)。
  • 高级别较低级别RET突变更频繁(68.8% vs 29.4%),RET-M918T突变也更频繁(46.9% vs 12.7%;p<0.001);RAS突变在高级别肿瘤中未见,在低级别肿瘤中为11.8%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: The International Medullary Thyroid Carcinoma Grading System (IMTCGS) divides medullary thyroid carcinoma (MTC) into two categories, high- and low-grade tumors, which has a profound impact on patient outcomes. The aim of this study was to explore the association between IMTCGS grading, clinical data, and molecular status in sporadic MTC. Methods: A retrospective cohort study was performed on consecutive sporadic MTCs from patients undergoing initial surgery between January 2000 and January 2022 at the Padua Endocrine Surgery Unit. Clinical, pathological, and follow-up data were collected, tumors were graded, and somatic mutations of RET and RAS genes were analyzed. Patient outcomes were based on Ct levels and MTC-related deaths. Survival analyses were carried out employing the Kaplan-Meier method and the log-rank test. A Cox proportional hazard regression model was employed for multivariable survival analysis with the following covariates: somatic RET mutation, MTC stage at diagnosis, sex, age at diagnosis, and IMTCGS grade. Results: We included 141 consecutive sporadic MTCs. The median follow-up was 80.0 months (interquartile ranges: 41.5-122.5 months). Seventeen patients (12.1%) died from disease-related causes. 107/141 (76.9%) were classified as low-grade tumors, 32/141 (23.1%) as high-grade. Patients carrying a RET mutation had more aggressive features and shorter disease-specific survival (DSS) (p = 0.001) and were more frequently classified high-grade than low-grade MTC (p < 0.001). At multivariable survival analysis, only IMTCGS grading was independently associated with DSS (hazard ratio 8.8 [confidence interval: 2.7-28.3], p = 0.005). RET mutations, in particular RET-M918T, were more frequent in high-grade than in low-grade MTC (68.8% vs. 29.4% mutated in RET, 46.9% vs. 12.7% mutated in RET-M918T; p < 0.001). None of the high-grade tumors was mutated in the RAS gene, but the mutation was present in 11.8% of low-grade tumors. Conclusions: IMTCGS grading was associated with DSS independently of other clinical, pathological, and molecular factors. Moreover, MTC grading was associated with RET and RAS patterns, which explains, at least in part, the molecular basis of the aggressive behavior of high-grade MTC.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Censi S, Galuppini F, Clausi C, et al. Tumor Grade and Molecular Characteristics Associated with Survival in Sporadic Medullary Thyroid Carcinoma. Thyroid. 2023. PMID: 38047536. doi:10.1089/thy.2023.0482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。